These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 8913505
1. Evaluation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. Hashimoto Y, Kagechika H, Kawachi E, Fukasawa H, Saito G, Shudo K. Biol Pharm Bull; 1996 Oct; 19(10):1322-8. PubMed ID: 8913505 [Abstract] [Full Text] [Related]
2. Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. Hashimoto Y, Kagechika H, Kawachi E, Fukasawa H, Saito G, Shudo K. J Cancer Res Clin Oncol; 1995 Oct; 121(11):696-8. PubMed ID: 7593136 [Abstract] [Full Text] [Related]
3. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells. Shibakura M, Koyama T, Saito T, Shudo K, Miyasaka N, Kamiyama R, Hirosawa S. Blood; 1997 Aug 15; 90(4):1545-51. PubMed ID: 9269772 [Abstract] [Full Text] [Related]
4. [Binding activity of retinoids with recombinant human retinoic acid receptor RAR alpha]. Cao X, Han R. Zhonghua Zhong Liu Za Zhi; 1998 May 15; 20(3):193-5. PubMed ID: 10921005 [Abstract] [Full Text] [Related]
5. The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha. Kamei Y, Kawada T, Mizukami J, Sugimoto E. Life Sci; 1994 May 15; 55(16):PL307-12. PubMed ID: 7934625 [Abstract] [Full Text] [Related]
6. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Idres N, Benoît G, Flexor MA, Lanotte M, Chabot GG. Cancer Res; 2001 Jan 15; 61(2):700-5. PubMed ID: 11212271 [Abstract] [Full Text] [Related]
7. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Meister B, Fink FM, Hittmair A, Marth C, Widschwendter M. Anticancer Res; 1998 Jan 15; 18(3A):1777-86. PubMed ID: 9673404 [Abstract] [Full Text] [Related]
13. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA, Dmitrovsky E. Differentiation; 1997 Aug 15; 61(5):321-31. PubMed ID: 9342843 [Abstract] [Full Text] [Related]
14. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring. Eyrolles L, Kagechika H, Kawachi E, Fukasawa H, Iijima T, Matsushima Y, Hashimoto Y, Shudo K. J Med Chem; 1994 May 13; 37(10):1508-17. PubMed ID: 8182710 [Abstract] [Full Text] [Related]
15. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. Charpentier B, Bernardon JM, Eustache J, Millois C, Martin B, Michel S, Shroot B. J Med Chem; 1995 Dec 22; 38(26):4993-5006. PubMed ID: 8544175 [Abstract] [Full Text] [Related]
16. Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells. Ivanova D, Gronemeyer H, de Lera AR. ChemMedChem; 2011 Aug 01; 6(8):1518-29. PubMed ID: 21506276 [Abstract] [Full Text] [Related]
17. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity. Muccio DD, Brouillette WJ, Alam M, Vaezi MF, Sani BP, Venepally P, Reddy L, Li E, Norris AW, Simpson-Herren L, Hill DL. J Med Chem; 1996 Sep 13; 39(19):3625-35. PubMed ID: 8809153 [Abstract] [Full Text] [Related]